Evidence map›Paper›PMID 23425360›Full record

ArticleBMC microbiology2013

The role of 3-ketosteroid 1(2)-dehydrogenase in the pathogenicity of Mycobacterium tuberculosis.

Marta Brzezinska, Izabela Szulc, Anna Brzostek, Magdalena Klink, Michal Kielbik, Zofia Sulowska, Jakub Pawelczyk, Jaroslaw Dziadek

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. 1,2-Hydrogenation and Transhydrogenation Catalyzed by 3-Ketosteroid ΔInternational journal of molecular sciences · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Mediators of inflammation · 2019
    Article
  7. New Insights on Steroid Biotechnology.Frontiers in microbiology · 2018
    Review
  8. Article
  9. Article
  10. Article
  11. Statins increase rifampin mycobactericidal effect.Antimicrobial agents and chemotherapy · 2014
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Marta BrzezinskaInstitute of Medical Biology, Polish Academy of Sciences, Lodowa 106 93-232, Lodz, Poland.
Izabela Szulc
Anna Brzostek
Magdalena Klink
Michal Kielbik
Zofia Sulowska
Jakub Pawelczyk
Jaroslaw Dziadek
Polish Academy of Sciences · PLInstitute for Medical Biology · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA growing body of evidence suggests that Mycobacterium tuberculosis (Mtb) uses the host's cholesterol as a source of carbon and energy during infection. Strains defective in cholesterol transport or degradation exhibit attenuated growth in activated macrophages and diminished infectivity in animal models. The aim of this study was to evaluate intracellular replication of a cholesterol degradation-deficient Mtb mutant in human macrophages (MØ) in vitro and assess the functional responses of Mtb mutant-infected MØ.

resultsA mutant Mtb H37Rv strain containing an inactivated kstD gene (∆kstD), which encodes 3-ketosteroid 1(2)-dehydrogenase (KstD), was previously prepared using the homologous recombination-based gene-replacement technique. A control strain carrying the kstD gene complemented with an intact kstD was also previously constructed. In this study, human resting MØ were obtained after overnight differentiation of the human monocyte-macrophage cell line THP-1. Resting MØ were further activated with interferon-γ (IFN-γ). The ability of the kstD-defective Mtb mutant strain to replicate intracellularly in human MØ was evaluated using a colony-forming assay. Nitric oxide (NO) and reactive oxygen species (ROS) production by MØ infected with wild-type or ∆kstD strains was detected using Griess reagent and chemiluminescence methods, respectively. The production of tumor necrosis factor-α and interleukin-10 by MØ after infection with wild-type or mutant Mtb was examined using enzyme-linked immunosorbent assays.We found that replication of mutant Mtb was attenuated in resting MØ compared to the wild-type or complemented strains. Moreover, the mutant was unable to inhibit the NO and ROS production induced through Toll-like receptor 2 (TLR2) signaling in infected resting MØ. In contrast, mutant and wild-type Mtb behaved similarly in MØ activated with IFN-γ before and during infection.

conclusionsThe Mtb mutant ∆kstD strain, which is unable to use cholesterol as a source of carbon and energy, has a limited ability to multiply in resting MØ following infection, reflecting a failure of the ∆kstD strain to inhibit the TLR2-dependent bactericidal activity of resting MØ.

Indexed as

Cell LineColony Count, MicrobialGene Knockout TechniquesGenetic Complementation TestHumansInterleukin-10MacrophagesMycobacterium tuberculosisNitric OxideOxidoreductasesReactive Oxygen SpeciesTumor Necrosis Factor-alphaVirulence Factors3-oxosteroid delta(1) dehydrogenaseInterleukin-10Nitric OxideOxidoreductasesReactive Oxygen SpeciesTumor Necrosis Factor-alphaVirulence Factors

Identifiers

PMID23425360
PMCPMC3599626
OpenAlexW1964202736

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.